May 15, 2019 / 04:20PM GMT
Jason Matthew Gerberry - BofA Merrill Lynch, Research Division - MD in US Equity Research
Going with our next company presenter. My name is Jason Gerberry. I'm the U.S. Pharma Analyst at Bank of America. I'm pleased to be introducing Eli Lilly and Enrique Conterno. Enrique runs Lilly's Diabetes Division. So very topical, as diabetes is an important growth driver for the company. Trulicity is very topical coming out of the quarter.
So thank you, Enrique, for joining us.
Enrique A. Conterno - Eli Lilly and Company - Senior VP & President of Lilly Diabetes and Lilly USA
Very good. No, pleasure to be here.
Jason Matthew Gerberry - BofA Merrill Lynch, Research Division - MD in US Equity Research
So maybe we can just start the discussion with your Trulicity franchise. It's obviously been one of the important growth drivers for the company, and really an impressive volume growth story for Lilly.
Can you talk about -- we've seen a very massive inflection in market share, I feel like, in the last 12 to
Eli Lilly and Co at Bank of America Merrill Lynch Health Care Conference Transcript
May 15, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers